. ([AAVL])
- - (-)
Market Cap: -
As of 12/31/69 07:00 PM EST. Market closed.
. ([AAVL])
-
- (-)
Market Cap: -
As of 12/31/69 07:00 PM EST. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
INSIDER TRANSACTIONS FOR
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Scopa James Paul | Director | Feb 07, 2024 | Buy | $1.35 | 100,000 | 135,000 | 100,000 | Feb 09, 2024, 05:51 PM |
Lupher, Jr. Mark L. | Director | Feb 07, 2024 | Buy | $1.35 | 130,000 | 175,500 | 130,000 | Feb 09, 2024, 05:50 PM |
Seyedkazemi Setareh | Chief Development Officer | Sep 15, 2023 | Sale | $1.52 | 6,201 | 9,429 | 47,804 | Sep 18, 2023, 06:54 PM |
Rubinstein Linda M | Chief Financial Officer | Jun 07, 2023 | Buy | $1.45 | 100,000 | 145,490 | 100,000 | Jun 09, 2023, 04:26 PM |
Riley Brigit | Chief Scientific Officer | Mar 15, 2023 | Sale | $0.78 | 7,299 | 5,705 | 117,435 | Mar 17, 2023, 06:02 PM |
Soparkar Peter | Chief Operating Officer | Mar 15, 2023 | Sale | $0.78 | 13,360 | 10,442 | 265,891 | Mar 17, 2023, 06:02 PM |
Fischer Laurent | CEO, President and Director | Mar 15, 2023 | Sale | $0.78 | 41,239 | 32,232 | 692,141 | Mar 17, 2023, 06:01 PM |
Beckman Richard | Chief Medical Officer | Sep 19, 2022 | Sale | $1.07 | 4,272 | 4,570 | 39,061 | Sep 21, 2022, 08:01 PM |
Seyedkazemi Setareh | Chief Development Officer | Sep 19, 2022 | Sale | $1.07 | 6,058 | 6,480 | 47,875 | Sep 21, 2022, 08:00 PM |
Soparkar Peter | See Remarks section | Sep 19, 2022 | Sale | $1.07 | 13,305 | 14,232 | 273,251 | Sep 21, 2022, 07:59 PM |
Riley Brigit | Chief Scientific Officer | Sep 19, 2022 | Sale | $1.07 | 7,266 | 7,772 | 118,734 | Sep 21, 2022, 07:58 PM |
Fischer Laurent | CEO, President and Director | Sep 19, 2022 | Sale | $1.07 | 41,082 | 43,941 | 727,380 | Sep 21, 2022, 07:57 PM |
Seyedkazemi Setareh | Chief Development Officer | May 23, 2022 | Buy | $0.84 | 20,000 | 16,800 | 20,600 | May 24, 2022, 04:47 PM |
Beckman Richard | Chief Medical Officer | May 17, 2022 | Buy | $0.82 | 10,000 | 8,228 | 10,000 | May 19, 2022, 07:43 PM |
Svoronos Dawn | Director | May 16, 2022 | Buy | $0.85 | 30,000 | 25,578 | 50,000 | May 18, 2022, 04:43 PM |
D'Souza Rupert | Chief Financial Officer | May 17, 2022 | Buy | $0.83 | 10,000 | 8,272 | 20,850 | May 17, 2022, 06:28 PM |
D'Souza Rupert | Chief Financial Officer | May 13, 2022 | Buy | $0.86 | 10,000 | 8,585 | 10,850 | May 17, 2022, 06:28 PM |
Fischer Laurent | CEO, President and Director | Apr 20, 2022 | Buy | $1.11 | 25,000 | 27,800 | 762,462 | Apr 22, 2022, 05:00 PM |
Soparkar Peter | See Remarks section | Apr 19, 2022 | Buy | $1.14 | 21,925 | 24,994 | 280,556 | Apr 20, 2022, 04:35 PM |
Fischer Laurent | CEO, President and Director | Dec 08, 2021 | Buy | $1.79 | 10,677 | 19,112 | 723,139 | Dec 10, 2021, 05:26 PM |
Fischer Laurent | CEO, President and Director | Dec 09, 2021 | Buy | $1.85 | 14,323 | 26,498 | 737,462 | Dec 10, 2021, 05:26 PM |
Soparkar Peter | See Remarks section | Dec 08, 2021 | Buy | $1.91 | 25,000 | 47,750 | 258,631 | Dec 10, 2021, 05:26 PM |
Scopa James Paul | Director | Nov 15, 2021 | Sale | $2.18 | 50,000 | 109,000 | 3,334 | Nov 17, 2021, 04:38 PM |
Clark Julie | Chief Medical Officer | Sep 30, 2021 | Sale | $2.17 | 4,766 | 10,342 | 164,723 | Oct 04, 2021, 05:36 PM |
Svoronos Dawn | Director | Mar 31, 2021 | Buy | $10.02 | 20,000 | 200,338 | 20,000 | Apr 01, 2021, 08:21 PM |
Fischer Laurent | CEO and Director | Mar 24, 2021 | Buy | $9.88 | 10,000 | 98,780 | 26,292 | Mar 24, 2021, 07:47 PM |
Machado Patrick | Director | Mar 24, 2021 | Buy | $9.92 | 10,000 | 99,196 | 88,182 | Mar 24, 2021, 07:46 PM |
PATTERSON LEONE D | President and CFO | Feb 09, 2021 | Sale | $14.10 | 12,533 | 176,718 | 98,017 | Feb 11, 2021, 07:47 PM |
Machado Patrick | Director | Jan 15, 2021 | Buy | $11.52 | 10,000 | 115,174 | 78,182 | Jan 19, 2021, 08:33 PM |
Fischer Laurent | CEO and Director | Jan 15, 2021 | Buy | $11.53 | 8,600 | 99,191 | 16,292 | Jan 19, 2021, 08:32 PM |
Soparkar Peter | Chief Legal Officer | Aug 17, 2020 | Buy | $13.00 | 7,692 | 99,996 | 10,692 | Aug 19, 2020, 06:48 PM |
Fischer Laurent | CEO and Director | Aug 17, 2020 | Buy | $13.00 | 7,692 | 99,996 | 7,692 | Aug 19, 2020, 06:45 PM |
Gasmi Mehdi | Director | Jul 20, 2020 | Option Exercise | $4.80 | 5,000 | 24,000 | 279,442 | Jul 22, 2020, 09:44 PM |
Gasmi Mehdi | Director | Jul 20, 2020 | Sale | $17.60 | 5,000 | 87,978 | 274,442 | Jul 22, 2020, 09:44 PM |
Gasmi Mehdi | Director | Jun 22, 2020 | Option Exercise | $4.80 | 23,605 | 113,304 | 298,047 | Jun 23, 2020, 06:58 PM |
Gasmi Mehdi | Director | Jun 22, 2020 | Sale | $25.06 | 23,605 | 591,617 | 274,442 | Jun 23, 2020, 06:58 PM |
Gasmi Mehdi | Director | Jun 17, 2020 | Option Exercise | $4.80 | 268 | 1,286 | 274,710 | Jun 18, 2020, 09:45 PM |
Gasmi Mehdi | Director | Jun 18, 2020 | Option Exercise | $4.80 | 11,127 | 53,410 | 285,569 | Jun 18, 2020, 09:45 PM |
Gasmi Mehdi | Director | Jun 18, 2020 | Sale | $25.01 | 11,127 | 278,329 | 274,442 | Jun 18, 2020, 09:45 PM |
Gasmi Mehdi | Director | Jun 17, 2020 | Sale | $25.01 | 268 | 6,703 | 274,442 | Jun 18, 2020, 09:45 PM |
PATTERSON LEONE D | President | Jun 16, 2020 | Sale | $24.68 | 13,171 | 325,060 | 110,488 | Jun 17, 2020, 05:47 PM |
Gasmi Mehdi | Director | Jun 15, 2020 | Option Exercise | $4.80 | 10,000 | 48,000 | 284,442 | Jun 17, 2020, 05:14 PM |
Gasmi Mehdi | Director | Jun 15, 2020 | Sale | $21.86 | 10,000 | 218,627 | 279,442 | Jun 17, 2020, 05:14 PM |
Gasmi Mehdi | Director | May 20, 2020 | Option Exercise | $4.80 | 1,401 | 6,725 | 275,843 | May 22, 2020, 06:55 PM |
Gasmi Mehdi | Director | May 21, 2020 | Option Exercise | $4.80 | 3,599 | 17,275 | 278,041 | May 22, 2020, 06:55 PM |
Gasmi Mehdi | Director | May 21, 2020 | Sale | $20.02 | 3,599 | 72,048 | 274,442 | May 22, 2020, 06:55 PM |
Gasmi Mehdi | Director | May 20, 2020 | Sale | $20.01 | 1,401 | 28,030 | 274,442 | May 22, 2020, 06:55 PM |
Gasmi Mehdi | Director | May 18, 2020 | Option Exercise | $4.80 | 5,000 | 24,000 | 279,442 | May 20, 2020, 07:34 PM |
Gasmi Mehdi | Director | May 06, 2020 | Option Exercise | $4.80 | 25,000 | 120,000 | 299,442 | May 20, 2020, 07:34 PM |
Gasmi Mehdi | Director | May 05, 2020 | Option Exercise | $4.80 | 10,000 | 48,000 | 284,442 | May 20, 2020, 07:34 PM |
Gasmi Mehdi | Director | May 18, 2020 | Sale | $18.17 | 5,000 | 90,833 | 274,742 | May 20, 2020, 07:34 PM |
Gasmi Mehdi | Director | May 06, 2020 | Sale | $20.03 | 25,000 | 500,667 | 274,442 | May 20, 2020, 07:34 PM |
Gasmi Mehdi | Director | May 05, 2020 | Sale | $16.26 | 10,000 | 162,573 | 274,442 | May 20, 2020, 07:34 PM |
Gasmi Mehdi | Director | Feb 12, 2020 | Option Exercise | $12.56 | 46,976 | 589,876 | 289,936 | May 20, 2020, 07:33 PM |
Gasmi Mehdi | Director | Feb 12, 2020 | Option Exercise | $4.80 | 10,000 | 48,000 | 284,442 | May 20, 2020, 07:33 PM |
Gasmi Mehdi | Director | Feb 12, 2020 | Sale | $15.07 | 10,000 | 150,690 | 274,442 | May 20, 2020, 07:33 PM |
PATTERSON LEONE D | CEO, President and Director | May 06, 2020 | Option Exercise | $3.44 | 20,000 | 68,800 | 143,659 | May 08, 2020, 06:25 PM |
PATTERSON LEONE D | CEO, President and Director | May 06, 2020 | Sale | $20.02 | 20,000 | 400,400 | 123,659 | May 08, 2020, 06:25 PM |
PATTERSON LEONE D | CEO, President and Director | Feb 09, 2020 | Option Exercise | $10.24 | 10,985 | 112,486 | 139,235 | May 08, 2020, 06:24 PM |
Scopa James Paul | Director | May 04, 2020 | Option Exercise | $6.48 | 23,334 | 151,204 | 53,334 | May 05, 2020, 06:44 PM |
PATTERSON LEONE D | CEO, President and Director | Mar 20, 2020 | Option Exercise | $3.44 | 24,424 | 84,019 | 162,955 | Mar 25, 2020, 05:28 PM |
PATTERSON LEONE D | CEO, President and Director | Mar 20, 2020 | Sale | $10.17 | 39,526 | 401,908 | 123,429 | Mar 25, 2020, 05:28 PM |
PATTERSON LEONE D | CEO, President and Director | Mar 17, 2020 | Sale | $10.02 | 474 | 4,749 | 138,531 | Mar 18, 2020, 07:33 PM |
Gasmi Mehdi | Director | Feb 18, 2020 | Option Exercise | $4.80 | 5,000 | 24,000 | 263,979 | Feb 20, 2020, 04:51 PM |
Gasmi Mehdi | Director | Feb 18, 2020 | Sale | $16.23 | 5,000 | 81,156 | 258,979 | Feb 20, 2020, 04:51 PM |
Scopa James Paul | Director | Feb 14, 2020 | Buy | $13.75 | 10,000 | 137,500 | 30,000 | Feb 14, 2020, 08:58 PM |
Gasmi Mehdi | Director | Feb 12, 2020 | Option Exercise | $12.56 | 46,945 | 589,525 | 289,967 | Feb 14, 2020, 08:57 PM |
Gasmi Mehdi | Director | Feb 12, 2020 | Option Exercise | $4.80 | 10,000 | 48,000 | 268,979 | Feb 14, 2020, 08:57 PM |
Gasmi Mehdi | Director | Feb 12, 2020 | Sale | $15.07 | 10,000 | 150,690 | 258,979 | Feb 14, 2020, 08:57 PM |
Gasmi Mehdi | Director | Feb 09, 2020 | Option Exercise | $10.24 | 15,494 | 158,659 | 274,473 | Feb 14, 2020, 08:55 PM |
Gasmi Mehdi | Director | Feb 09, 2020 | Option Exercise | $10.24 | 11,551 | 118,282 | 309,867 | Feb 10, 2020, 07:57 AM |
PATTERSON LEONE D | CEO, President and Director | Feb 09, 2020 | Option Exercise | $10.24 | 11,215 | 114,842 | 139,005 | Feb 10, 2020, 07:56 AM |
PATTERSON LEONE D | CEO, President and Director | Dec 23, 2019 | Sale | $10.72 | 40,000 | 428,800 | 150,220 | Feb 10, 2020, 07:54 AM |
Gasmi Mehdi | Director | Feb 09, 2018 | Option Exercise | $7.05 | 11,433 | 80,603 | 259,173 | Feb 10, 2020, 07:52 AM |
Gasmi Mehdi | Director | Aug 21, 2017 | Option Exercise | $2.50 | 5,479 | 13,698 | 270,606 | Feb 10, 2020, 07:52 AM |
Gasmi Mehdi | Director | Apr 21, 2019 | Option Exercise | $5.98 | 589 | 3,522 | 321,418 | Feb 10, 2020, 07:52 AM |
Gasmi Mehdi | Director | Apr 21, 2017 | Option Exercise | $2.70 | 657 | 1,774 | 276,085 | Feb 10, 2020, 07:52 AM |
Gasmi Mehdi | Director | Feb 12, 2019 | Option Exercise | $3.55 | 10,652 | 37,815 | 322,007 | Feb 10, 2020, 07:52 AM |
Gasmi Mehdi | Director | Feb 12, 2017 | Option Exercise | $3.00 | 12,793 | 38,379 | 276,742 | Feb 10, 2020, 07:52 AM |
Gasmi Mehdi | Director | Feb 09, 2019 | Option Exercise | $3.33 | 12,599 | 41,955 | 332,659 | Feb 10, 2020, 07:52 AM |
Gasmi Mehdi | Director | Apr 21, 2018 | Option Exercise | $6.30 | 605 | 3,812 | 247,762 | Feb 10, 2020, 07:52 AM |
Gasmi Mehdi | Director | Feb 12, 2018 | Option Exercise | $6.85 | 10,806 | 74,021 | 248,367 | Feb 10, 2020, 07:52 AM |
PATTERSON LEONE D | CEO, President and Director | Feb 09, 2018 | Option Exercise | $7.05 | 8,208 | 57,866 | 162,397 | Feb 10, 2020, 07:51 AM |
PATTERSON LEONE D | CEO, President and Director | Jun 15, 2017 | Option Exercise | $2.70 | 9,395 | 25,367 | 170,605 | Feb 10, 2020, 07:51 AM |
PATTERSON LEONE D | CEO, President and Director | Jun 15, 2019 | Option Exercise | $10.82 | 43,852 | 474,479 | 225,502 | Feb 10, 2020, 07:51 AM |
PATTERSON LEONE D | CEO, President and Director | Feb 09, 2019 | Option Exercise | $3.33 | 8,176 | 27,226 | 234,072 | Feb 10, 2020, 07:51 AM |
PATTERSON LEONE D | CEO, President and Director | Jun 15, 2018 | Option Exercise | $5.55 | 8,645 | 47,980 | 242,248 | Feb 10, 2020, 07:51 AM |
PATTERSON LEONE D | CEO, President and Director | Dec 23, 2019 | Sale | $10.72 | 40,000 | 428,800 | 228,496 | Dec 26, 2019, 04:47 PM |
Scopa James Paul | Director | May 06, 2019 | Buy | $6.71 | 20,000 | 134,200 | 20,000 | May 06, 2019, 07:42 PM |
Gasmi Mehdi | SVP,Pharmaceutical Development | Jun 15, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | Jun 17, 2015, 08:33 PM |
Gasmi Mehdi | SVP,Pharmaceutical Development | Jun 15, 2015 | Sale | $39.86 | 500 | 19,931 | 7,000 | Jun 17, 2015, 08:33 PM |
Wachter Paul | Director | Jun 15, 2015 | Sale | $39.86 | 1,192 | 47,516 | 37,161 | Jun 17, 2015, 08:33 PM |
Schwartz Steven Daniel | Director | Jun 15, 2015 | Sale | $39.86 | 16,875 | 672,671 | 367,931 | Jun 17, 2015, 08:33 PM |
Hull Hans | SVP, Business Operations | Jun 12, 2015 | Option Exercise | $0.19 | 8,300 | 1,577 | 19,620 | Jun 16, 2015, 06:25 PM |
Blumenkranz Mark S. | Director | Jun 11, 2015 | Sale | $39.97 | 1,900 | 75,939 | 522,989 | Jun 15, 2015, 05:01 PM |
Bain Linda | Chief Financial Officer | Jun 12, 2015 | Option Exercise | $3.15 | 3,500 | 11,025 | 12,500 | Jun 15, 2015, 05:00 PM |
Bain Linda | Chief Financial Officer | Jun 12, 2015 | Sale | $39.94 | 3,500 | 139,795 | 9,000 | Jun 15, 2015, 05:00 PM |
GUERIN JOHN PATRICK ET AL | Director | Jun 10, 2015 | Sale | $206.00 | 699 | 143,994 | 150,000 | Jun 11, 2015, 09:09 PM |
GUERIN JOHN PATRICK ET AL | Director | May 28, 2015 | Sale | $208.00 | 1 | 208 | 150,699 | Jun 11, 2015, 09:09 PM |
GUERIN JOHN PATRICK ET AL | Director | May 27, 2015 | Sale | $206.00 | 1,205 | 248,230 | 150,700 | Jun 11, 2015, 09:09 PM |
Blumenkranz Mark S. | Director | Jun 10, 2015 | Sale | $39.91 | 600 | 23,948 | 524,889 | Jun 11, 2015, 06:21 PM |
Blumenkranz Mark S. | Director | Jun 09, 2015 | Sale | $35.75 | 22,500 | 804,328 | 532,689 | Jun 11, 2015, 06:21 PM |
Chalberg Thomas W. | Chief Executive Officer | Jun 10, 2015 | Sale | $38.05 | 25,000 | 951,194 | 278,953 | Jun 11, 2015, 06:21 PM |
Wachter Paul | Director | Jun 08, 2015 | Sale | $38.64 | 1,192 | 46,061 | 39,004 | Jun 10, 2015, 08:29 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | Jun 08, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | Jun 10, 2015, 08:28 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | Jun 08, 2015 | Sale | $38.64 | 500 | 19,321 | 7,265 | Jun 10, 2015, 08:28 PM |
Blumenkranz Mark S. | Director | Jun 05, 2015 | Sale | $40.08 | 5,000 | 200,414 | 547,989 | Jun 08, 2015, 05:20 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | May 28, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | Jun 05, 2015, 08:00 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | May 28, 2015 | Sale | $38.02 | 500 | 19,009 | 7,000 | Jun 05, 2015, 08:00 PM |
Hull Hans | SVP, Business Operations | Jun 04, 2015 | Option Exercise | $0.19 | 2,000 | 380 | 13,320 | Jun 05, 2015, 05:59 PM |
Hull Hans | SVP, Business Operations | Jun 04, 2015 | Sale | $37.64 | 2,000 | 75,283 | 11,320 | Jun 05, 2015, 05:59 PM |
Wachter Paul | Director | Jun 01, 2015 | Sale | $36.23 | 1,192 | 43,191 | 39,755 | Jun 02, 2015, 08:24 PM |
Schwartz Steven Daniel | Director | Jun 01, 2015 | Sale | $36.23 | 17,250 | 625,043 | 387,899 | Jun 02, 2015, 08:24 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | May 28, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | May 29, 2015, 02:37 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | May 28, 2015 | Sale | $38.02 | 500 | 19,009 | 7,000 | May 29, 2015, 02:37 PM |
Wachter Paul | Director | May 26, 2015 | Sale | $36.94 | 1,192 | 44,037 | 41,143 | May 27, 2015, 06:39 PM |
Schwartz Steven Daniel | Director | May 22, 2015 | Sale | $38.38 | 16,875 | 647,687 | 407,252 | May 22, 2015, 07:21 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | May 21, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | May 22, 2015, 04:36 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | May 21, 2015 | Sale | $38.87 | 500 | 19,435 | 7,000 | May 22, 2015, 04:36 PM |
Blumenkranz Mark S. | Director | May 19, 2015 | Sale | $36.91 | 3,000 | 110,734 | 10,531 | May 21, 2015, 05:53 PM |
Wachter Paul | Director | May 18, 2015 | Sale | $35.31 | 1,192 | 42,086 | 41,929 | May 19, 2015, 06:24 PM |
Blumenkranz Mark S. | Director | May 15, 2015 | Sale | $35.49 | 22,500 | 798,553 | 557,514 | May 18, 2015, 05:22 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | May 14, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | May 15, 2015, 05:47 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | May 14, 2015 | Sale | $35.31 | 500 | 17,656 | 7,000 | May 15, 2015, 05:47 PM |
Blumenkranz Mark S. | Director | May 13, 2015 | Sale | $34.94 | 715 | 24,984 | 575,489 | May 13, 2015, 07:16 PM |
Bain Linda | Chief Financial Officer | May 13, 2015 | Option Exercise | $3.15 | 285 | 898 | 9,285 | May 13, 2015, 07:15 PM |
Bain Linda | Chief Financial Officer | May 13, 2015 | Sale | $34.94 | 285 | 9,959 | 9,000 | May 13, 2015, 07:15 PM |
Wachter Paul | Director | May 11, 2015 | Sale | $33.38 | 1,192 | 39,792 | 43,805 | May 12, 2015, 05:05 PM |
Bain Linda | Chief Financial Officer | May 11, 2015 | Option Exercise | $3.15 | 715 | 2,252 | 9,715 | May 12, 2015, 05:03 PM |
Bain Linda | Chief Financial Officer | May 11, 2015 | Sale | $34.91 | 715 | 24,964 | 9,000 | May 12, 2015, 05:03 PM |
Blumenkranz Mark S. | Director | May 11, 2015 | Sale | $34.91 | 1,785 | 62,323 | 576,204 | May 12, 2015, 05:00 PM |
Schwartz Steven Daniel | Director | May 08, 2015 | Sale | $33.05 | 17,250 | 570,092 | 418,931 | May 11, 2015, 05:00 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | May 07, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | May 08, 2015, 07:09 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | May 07, 2015 | Sale | $33.28 | 500 | 16,638 | 7,000 | May 08, 2015, 07:09 PM |
Chalberg Thomas W. | Chief Executive Officer | May 05, 2015 | Sale | $30.00 | 25,000 | 750,093 | 283,988 | May 07, 2015, 04:16 PM |
Hull Hans | SVP, Business Operations | May 04, 2015 | Option Exercise | $0.19 | 5,000 | 950 | 16,320 | May 06, 2015, 04:06 PM |
Hull Hans | SVP, Business Operations | May 04, 2015 | Sale | $30.87 | 5,000 | 154,349 | 11,320 | May 06, 2015, 04:06 PM |
Bain Linda | Chief Financial Officer | May 04, 2015 | Option Exercise | $3.15 | 2,500 | 7,875 | 11,500 | May 06, 2015, 04:06 PM |
Bain Linda | Chief Financial Officer | May 04, 2015 | Sale | $31.59 | 2,500 | 78,972 | 9,000 | May 06, 2015, 04:06 PM |
Wachter Paul | Director | May 04, 2015 | Sale | $30.87 | 1,192 | 36,797 | 44,313 | May 06, 2015, 04:05 PM |
Blumenkranz Mark S. | Director | May 01, 2015 | Sale | $32.37 | 20,000 | 647,306 | 577,989 | May 05, 2015, 04:06 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | Apr 28, 2015 | Option Exercise | $2.75 | 1,000 | 2,750 | 8,000 | Apr 30, 2015, 06:51 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | Apr 28, 2015 | Sale | $35.67 | 1,000 | 35,667 | 7,000 | Apr 30, 2015, 06:51 PM |
Wachter Paul | Director | Apr 27, 2015 | Sale | $35.61 | 1,192 | 42,443 | 45,505 | Apr 29, 2015, 05:47 PM |
Schwartz Steven Daniel | Director | Apr 23, 2015 | Sale | $38.62 | 16,875 | 651,665 | 436,181 | Apr 23, 2015, 07:52 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | Apr 21, 2015 | Option Exercise | $2.75 | 1,000 | 2,750 | 1,000 | Apr 23, 2015, 04:58 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | Apr 21, 2015 | Sale | $39.21 | 1,000 | 39,211 | 0 | Apr 23, 2015, 04:58 PM |
Wachter Paul | Director | Apr 20, 2015 | Sale | $40.19 | 1,192 | 47,910 | 46,697 | Apr 21, 2015, 05:49 PM |
Blumenkranz Mark S. | Director | Apr 16, 2015 | Sale | $41.59 | 25,000 | 1,039,753 | 596,189 | Apr 20, 2015, 05:37 PM |
Zygtech, LLC | 10% Owner | Apr 14, 2015 | Sale | $39.93 | 4,600 | 183,663 | 2,438,176 | Apr 15, 2015, 05:25 PM |
Zygtech, LLC | 10% Owner | Apr 13, 2015 | Sale | $39.46 | 20,400 | 805,009 | 2,450,902 | Apr 15, 2015, 05:25 PM |
Wachter Paul | Director | Apr 13, 2015 | Sale | $39.34 | 1,192 | 46,896 | 48,251 | Apr 15, 2015, 05:25 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | Apr 14, 2015 | Option Exercise | $2.75 | 1,000 | 2,750 | 1,000 | Apr 15, 2015, 05:24 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | Apr 14, 2015 | Sale | $39.45 | 1,000 | 39,448 | 0 | Apr 15, 2015, 05:24 PM |
Schwartz Steven Daniel | Director | Apr 09, 2015 | Sale | $39.73 | 17,250 | 685,278 | 451,256 | Apr 13, 2015, 04:47 PM |
Blumenkranz Mark S. | Director | Apr 07, 2015 | Sale | $38.60 | 3,000 | 115,808 | 11,563 | Apr 08, 2015, 04:47 PM |
Blumenkranz Mark S. | Director | Apr 08, 2015 | Sale | $39.94 | 2,500 | 99,841 | 620,989 | Apr 08, 2015, 04:47 PM |
Blumenkranz Mark S. | Director | Apr 07, 2015 | Sale | $38.60 | 22,500 | 868,560 | 624,215 | Apr 08, 2015, 04:47 PM |
Hull Hans | SVP, Business Operations | Apr 07, 2015 | Option Exercise | $0.19 | 27,500 | 5,225 | 30,820 | Apr 08, 2015, 04:32 PM |
Hull Hans | SVP, Business Operations | Apr 07, 2015 | Sale | $38.60 | 27,500 | 1,061,573 | 4,207 | Apr 08, 2015, 04:32 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | Apr 07, 2015 | Option Exercise | $2.75 | 9,000 | 24,750 | 9,000 | Apr 08, 2015, 04:29 PM |
Gasmi Mehdi | VP, Pharmaceutical Development | Apr 07, 2015 | Sale | $38.60 | 9,000 | 347,425 | 292 | Apr 08, 2015, 04:29 PM |
Zygtech, LLC | 10% Owner | Jan 13, 2015 | Sale | $55.46 | 100,000 | 5,546,000 | 2,463,176 | Jan 15, 2015, 05:00 PM |
Wachter Paul | Director | Jan 13, 2015 | Sale | $55.46 | 14,000 | 776,440 | 49,081 | Jan 15, 2015, 04:59 PM |
Schwartz Steven Daniel | Director | Jan 13, 2015 | Sale | $55.46 | 91,000 | 5,046,860 | 468,306 | Jan 15, 2015, 04:58 PM |
Chalberg Thomas W. | Chief Executive Officer | Jan 13, 2015 | Sale | $55.46 | 85,000 | 4,714,100 | 285,988 | Jan 15, 2015, 04:58 PM |
Blumenkranz Mark S. | Director | Jan 13, 2015 | Sale | $55.46 | 100,000 | 5,546,000 | 645,989 | Jan 15, 2015, 04:57 PM |
Chalberg Thomas W. | Chief Executive Officer | Dec 12, 2014 | Option Exercise | $0.21 | 413 | 87 | 371,401 | Jan 14, 2015, 05:43 PM |
Venrock Healthcare Capital Partners II, L.P. | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 400,000 | 6,800,000 | 2,365,471 | Aug 07, 2014, 03:18 PM |
Venrock Associates VI, L.P. | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 400,000 | 6,800,000 | 2,365,471 | Aug 07, 2014, 03:17 PM |
Schwartz Steven Daniel | Director | Aug 05, 2014 | Option Exercise | $0.15 | 34,000 | 5,100 | 534,000 | Aug 07, 2014, 03:11 PM |
Blumenkranz Mark S. | Director | Aug 05, 2014 | Option Exercise | $0.15 | 25,000 | 3,750 | 725,000 | Aug 07, 2014, 03:07 PM |
REGENERON PHARMACEUTICALS INC | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 588,235 | 9,999,995 | 1,809,098 | Aug 05, 2014, 05:39 PM |
Flynn James E | 10% Owner | Aug 05, 2014 | Buy | $25.14 | 627,267 | 15,770,984 | 627,267 | Aug 05, 2014, 05:26 PM |
Flynn James E | 10% Owner | Aug 05, 2014 | Buy | $25.14 | 507,200 | 12,752,446 | 507,200 | Aug 05, 2014, 05:26 PM |
Flynn James E | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 123,077 | 2,092,309 | 654,285 | Aug 05, 2014, 05:26 PM |
Flynn James E | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 34,223 | 581,791 | 181,633 | Aug 05, 2014, 05:26 PM |
Flynn James E | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 42,700 | 725,900 | 227,294 | Aug 05, 2014, 05:26 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Scopa James Paul | Director | 02/07/2024 | 135,000 |
Lupher, Jr. Mark L. | Director | 02/07/2024 | 175,500 |
Seyedkazemi Setareh | Chief Development Officer | 09/15/2023 | 9,429 |
Rubinstein Linda M | Chief Financial Officer | 06/07/2023 | 145,490 |
Riley Brigit | Chief Scientific Officer | 03/15/2023 | 5,705 |
Soparkar Peter | Chief Operating Officer | 03/15/2023 | 10,442 |
Fischer Laurent | CEO, President and Director | 03/15/2023 | 32,232 |
Beckman Richard | Chief Medical Officer | 09/19/2022 | 4,570 |
Seyedkazemi Setareh | Chief Development Officer | 09/19/2022 | 6,480 |
Soparkar Peter | See Remarks section | 09/19/2022 | 14,232 |
Riley Brigit | Chief Scientific Officer | 09/19/2022 | 7,772 |
Fischer Laurent | CEO, President and Director | 09/19/2022 | 43,941 |
Seyedkazemi Setareh | Chief Development Officer | 05/23/2022 | 16,800 |
Beckman Richard | Chief Medical Officer | 05/17/2022 | 8,228 |
Svoronos Dawn | Director | 05/16/2022 | 25,578 |
D'Souza Rupert | Chief Financial Officer | 05/17/2022 | 8,272 |
D'Souza Rupert | Chief Financial Officer | 05/13/2022 | 8,585 |
Fischer Laurent | CEO, President and Director | 04/20/2022 | 27,800 |
Soparkar Peter | See Remarks section | 04/19/2022 | 24,994 |
Fischer Laurent | CEO, President and Director | 12/08/2021 | 19,112 |
Fischer Laurent | CEO, President and Director | 12/09/2021 | 26,498 |
Soparkar Peter | See Remarks section | 12/08/2021 | 47,750 |
Scopa James Paul | Director | 11/15/2021 | 109,000 |
Clark Julie | Chief Medical Officer | 09/30/2021 | 10,342 |
Svoronos Dawn | Director | 03/31/2021 | 200,338 |
Fischer Laurent | CEO and Director | 03/24/2021 | 98,780 |
Machado Patrick | Director | 03/24/2021 | 99,196 |
PATTERSON LEONE D | President and CFO | 02/09/2021 | 176,718 |
Machado Patrick | Director | 01/15/2021 | 115,174 |
Fischer Laurent | CEO and Director | 01/15/2021 | 99,191 |
Soparkar Peter | Chief Legal Officer | 08/17/2020 | 99,996 |
Fischer Laurent | CEO and Director | 08/17/2020 | 99,996 |
Gasmi Mehdi | Director | 07/20/2020 | 24,000 |
Gasmi Mehdi | Director | 07/20/2020 | 87,978 |
Gasmi Mehdi | Director | 06/22/2020 | 113,304 |
Gasmi Mehdi | Director | 06/22/2020 | 591,617 |
Gasmi Mehdi | Director | 06/17/2020 | 1,286 |
Gasmi Mehdi | Director | 06/18/2020 | 53,410 |
Gasmi Mehdi | Director | 06/18/2020 | 278,329 |
Gasmi Mehdi | Director | 06/17/2020 | 6,703 |
PATTERSON LEONE D | President | 06/16/2020 | 325,060 |
Gasmi Mehdi | Director | 06/15/2020 | 48,000 |
Gasmi Mehdi | Director | 06/15/2020 | 218,627 |
Gasmi Mehdi | Director | 05/20/2020 | 6,725 |
Gasmi Mehdi | Director | 05/21/2020 | 17,275 |
Gasmi Mehdi | Director | 05/21/2020 | 72,048 |
Gasmi Mehdi | Director | 05/20/2020 | 28,030 |
Gasmi Mehdi | Director | 05/18/2020 | 24,000 |
Gasmi Mehdi | Director | 05/06/2020 | 120,000 |
Gasmi Mehdi | Director | 05/05/2020 | 48,000 |
Gasmi Mehdi | Director | 05/18/2020 | 90,833 |
Gasmi Mehdi | Director | 05/06/2020 | 500,667 |
Gasmi Mehdi | Director | 05/05/2020 | 162,573 |
Gasmi Mehdi | Director | 02/12/2020 | 589,876 |
Gasmi Mehdi | Director | 02/12/2020 | 48,000 |
Gasmi Mehdi | Director | 02/12/2020 | 150,690 |
PATTERSON LEONE D | CEO, President and Director | 05/06/2020 | 68,800 |
PATTERSON LEONE D | CEO, President and Director | 05/06/2020 | 400,400 |
PATTERSON LEONE D | CEO, President and Director | 02/09/2020 | 112,486 |
Scopa James Paul | Director | 05/04/2020 | 151,204 |
PATTERSON LEONE D | CEO, President and Director | 03/20/2020 | 84,019 |
PATTERSON LEONE D | CEO, President and Director | 03/20/2020 | 401,908 |
PATTERSON LEONE D | CEO, President and Director | 03/17/2020 | 4,749 |
Gasmi Mehdi | Director | 02/18/2020 | 24,000 |
Gasmi Mehdi | Director | 02/18/2020 | 81,156 |
Scopa James Paul | Director | 02/14/2020 | 137,500 |
Gasmi Mehdi | Director | 02/12/2020 | 589,525 |
Gasmi Mehdi | Director | 02/12/2020 | 48,000 |
Gasmi Mehdi | Director | 02/12/2020 | 150,690 |
Gasmi Mehdi | Director | 02/09/2020 | 158,659 |
Gasmi Mehdi | Director | 02/09/2020 | 118,282 |
PATTERSON LEONE D | CEO, President and Director | 02/09/2020 | 114,842 |
PATTERSON LEONE D | CEO, President and Director | 12/23/2019 | 428,800 |
Gasmi Mehdi | Director | 02/09/2018 | 80,603 |
Gasmi Mehdi | Director | 08/21/2017 | 13,698 |
Gasmi Mehdi | Director | 04/21/2019 | 3,522 |
Gasmi Mehdi | Director | 04/21/2017 | 1,774 |
Gasmi Mehdi | Director | 02/12/2019 | 37,815 |
Gasmi Mehdi | Director | 02/12/2017 | 38,379 |
Gasmi Mehdi | Director | 02/09/2019 | 41,955 |
Gasmi Mehdi | Director | 04/21/2018 | 3,812 |
Gasmi Mehdi | Director | 02/12/2018 | 74,021 |
PATTERSON LEONE D | CEO, President and Director | 02/09/2018 | 57,866 |
PATTERSON LEONE D | CEO, President and Director | 06/15/2017 | 25,367 |
PATTERSON LEONE D | CEO, President and Director | 06/15/2019 | 474,479 |
PATTERSON LEONE D | CEO, President and Director | 02/09/2019 | 27,226 |
PATTERSON LEONE D | CEO, President and Director | 06/15/2018 | 47,980 |
PATTERSON LEONE D | CEO, President and Director | 12/23/2019 | 428,800 |
Scopa James Paul | Director | 05/06/2019 | 134,200 |
Gasmi Mehdi | SVP,Pharmaceutical Development | 06/15/2015 | 1,375 |
Gasmi Mehdi | SVP,Pharmaceutical Development | 06/15/2015 | 19,931 |
Wachter Paul | Director | 06/15/2015 | 47,516 |
Schwartz Steven Daniel | Director | 06/15/2015 | 672,671 |
Hull Hans | SVP, Business Operations | 06/12/2015 | 1,577 |
Blumenkranz Mark S. | Director | 06/11/2015 | 75,939 |
Bain Linda | Chief Financial Officer | 06/12/2015 | 11,025 |
Bain Linda | Chief Financial Officer | 06/12/2015 | 139,795 |
GUERIN JOHN PATRICK ET AL | Director | 06/10/2015 | 143,994 |
GUERIN JOHN PATRICK ET AL | Director | 05/28/2015 | 208 |
GUERIN JOHN PATRICK ET AL | Director | 05/27/2015 | 248,230 |
Blumenkranz Mark S. | Director | 06/10/2015 | 23,948 |
Blumenkranz Mark S. | Director | 06/09/2015 | 804,328 |
Chalberg Thomas W. | Chief Executive Officer | 06/10/2015 | 951,194 |
Wachter Paul | Director | 06/08/2015 | 46,061 |
Gasmi Mehdi | VP, Pharmaceutical Development | 06/08/2015 | 1,375 |
Gasmi Mehdi | VP, Pharmaceutical Development | 06/08/2015 | 19,321 |
Blumenkranz Mark S. | Director | 06/05/2015 | 200,414 |
Gasmi Mehdi | VP, Pharmaceutical Development | 05/28/2015 | 1,375 |
Gasmi Mehdi | VP, Pharmaceutical Development | 05/28/2015 | 19,009 |
Hull Hans | SVP, Business Operations | 06/04/2015 | 380 |
Hull Hans | SVP, Business Operations | 06/04/2015 | 75,283 |
Wachter Paul | Director | 06/01/2015 | 43,191 |
Schwartz Steven Daniel | Director | 06/01/2015 | 625,043 |
Gasmi Mehdi | VP, Pharmaceutical Development | 05/28/2015 | 1,375 |
Gasmi Mehdi | VP, Pharmaceutical Development | 05/28/2015 | 19,009 |
Wachter Paul | Director | 05/26/2015 | 44,037 |
Schwartz Steven Daniel | Director | 05/22/2015 | 647,687 |
Gasmi Mehdi | VP, Pharmaceutical Development | 05/21/2015 | 1,375 |
Gasmi Mehdi | VP, Pharmaceutical Development | 05/21/2015 | 19,435 |
Blumenkranz Mark S. | Director | 05/19/2015 | 110,734 |
Wachter Paul | Director | 05/18/2015 | 42,086 |
Blumenkranz Mark S. | Director | 05/15/2015 | 798,553 |
Gasmi Mehdi | VP, Pharmaceutical Development | 05/14/2015 | 1,375 |
Gasmi Mehdi | VP, Pharmaceutical Development | 05/14/2015 | 17,656 |
Blumenkranz Mark S. | Director | 05/13/2015 | 24,984 |
Bain Linda | Chief Financial Officer | 05/13/2015 | 898 |
Bain Linda | Chief Financial Officer | 05/13/2015 | 9,959 |
Wachter Paul | Director | 05/11/2015 | 39,792 |
Bain Linda | Chief Financial Officer | 05/11/2015 | 2,252 |
Bain Linda | Chief Financial Officer | 05/11/2015 | 24,964 |
Blumenkranz Mark S. | Director | 05/11/2015 | 62,323 |
Schwartz Steven Daniel | Director | 05/08/2015 | 570,092 |
Gasmi Mehdi | VP, Pharmaceutical Development | 05/07/2015 | 1,375 |
Gasmi Mehdi | VP, Pharmaceutical Development | 05/07/2015 | 16,638 |
Chalberg Thomas W. | Chief Executive Officer | 05/05/2015 | 750,093 |
Hull Hans | SVP, Business Operations | 05/04/2015 | 950 |
Hull Hans | SVP, Business Operations | 05/04/2015 | 154,349 |
Bain Linda | Chief Financial Officer | 05/04/2015 | 7,875 |
Bain Linda | Chief Financial Officer | 05/04/2015 | 78,972 |
Wachter Paul | Director | 05/04/2015 | 36,797 |
Blumenkranz Mark S. | Director | 05/01/2015 | 647,306 |
Gasmi Mehdi | VP, Pharmaceutical Development | 04/28/2015 | 2,750 |
Gasmi Mehdi | VP, Pharmaceutical Development | 04/28/2015 | 35,667 |
Wachter Paul | Director | 04/27/2015 | 42,443 |
Schwartz Steven Daniel | Director | 04/23/2015 | 651,665 |
Gasmi Mehdi | VP, Pharmaceutical Development | 04/21/2015 | 2,750 |
Gasmi Mehdi | VP, Pharmaceutical Development | 04/21/2015 | 39,211 |
Wachter Paul | Director | 04/20/2015 | 47,910 |
Blumenkranz Mark S. | Director | 04/16/2015 | 1,039,753 |
Zygtech, LLC | 10% Owner | 04/14/2015 | 183,663 |
Zygtech, LLC | 10% Owner | 04/13/2015 | 805,009 |
Wachter Paul | Director | 04/13/2015 | 46,896 |
Gasmi Mehdi | VP, Pharmaceutical Development | 04/14/2015 | 2,750 |
Gasmi Mehdi | VP, Pharmaceutical Development | 04/14/2015 | 39,448 |
Schwartz Steven Daniel | Director | 04/09/2015 | 685,278 |
Blumenkranz Mark S. | Director | 04/07/2015 | 115,808 |
Blumenkranz Mark S. | Director | 04/08/2015 | 99,841 |
Blumenkranz Mark S. | Director | 04/07/2015 | 868,560 |
Hull Hans | SVP, Business Operations | 04/07/2015 | 5,225 |
Hull Hans | SVP, Business Operations | 04/07/2015 | 1,061,573 |
Gasmi Mehdi | VP, Pharmaceutical Development | 04/07/2015 | 24,750 |
Gasmi Mehdi | VP, Pharmaceutical Development | 04/07/2015 | 347,425 |
Zygtech, LLC | 10% Owner | 01/13/2015 | 5,546,000 |
Wachter Paul | Director | 01/13/2015 | 776,440 |
Schwartz Steven Daniel | Director | 01/13/2015 | 5,046,860 |
Chalberg Thomas W. | Chief Executive Officer | 01/13/2015 | 4,714,100 |
Blumenkranz Mark S. | Director | 01/13/2015 | 5,546,000 |
Chalberg Thomas W. | Chief Executive Officer | 12/12/2014 | 87 |
Venrock Healthcare Capital Partners II, L.P. | 10% Owner | 08/05/2014 | 6,800,000 |
Venrock Associates VI, L.P. | 10% Owner | 08/05/2014 | 6,800,000 |
Schwartz Steven Daniel | Director | 08/05/2014 | 5,100 |
Blumenkranz Mark S. | Director | 08/05/2014 | 3,750 |
REGENERON PHARMACEUTICALS INC | 10% Owner | 08/05/2014 | 9,999,995 |
Flynn James E | 10% Owner | 08/05/2014 | 15,770,984 |
Flynn James E | 10% Owner | 08/05/2014 | 12,752,446 |
Flynn James E | 10% Owner | 08/05/2014 | 2,092,309 |
Flynn James E | 10% Owner | 08/05/2014 | 581,791 |
Flynn James E | 10% Owner | 08/05/2014 | 725,900 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR
STOCK BUYBACKS FOR
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.22%
1Q
06/30/2023
0.45%
2Q
03/31/2023
0.91%
3Q
12/31/2022
1.29%
4Q
09/30/2022
1.75%
5Q
06/30/2022
2.24%
6Q
03/31/2022
2.66%
7Q
12/31/2021
3.01%
8Q
09/30/2021
3.15%
9Q
06/30/2021
3.26%
10Q
03/31/2021
3.55%
11Q
12/31/2020
3.71%
12Q
09/30/2020
13.90%
13Q
06/30/2020
26.16%
14Q
03/31/2020
37.16%
15Q
12/31/2019
55.44%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...